Huertas V E, Port F K, Rozas V V, Niederhuber J E
Arch Surg. 1976 Feb;111(2):162-6. doi: 10.1001/archsurg.1976.01360200068012.
Pneumonia developed in 33 of 266 renal transplant recipients while they were receiving immunosuppressive therapy. Clinical factors were compared for patients with pneumonia and the control group of 220 transplant recipients without pneumonia. The diagnosis was usually established roentgenographically. Most cases of pneumonia were of bacterial origin and occurred within three months after transplantation. Pneumonia occurring during the first two postoperative weeks had no fatal outcomes. Patients with pneumonia occurring three to 12 weeks after transplantation had significantly greater leukopenia (P less than .05) and more therapy for allograft rejection (P less than .01) than the control group. Cases of fungal pneumonia developed later, were preceded by rejection, and had a poor prognosis. The mortality was 51.5% for all cases of pneumonia. Early diagnosis, prompt administration of specific antimicrobial agents, and immediate cessation of immunosuppressive therapy should improve the survival rate.
266例肾移植受者在接受免疫抑制治疗期间有33例发生了肺炎。对发生肺炎的患者以及220例未发生肺炎的移植受者对照组的临床因素进行了比较。诊断通常通过X线检查确定。大多数肺炎病例为细菌感染,且发生在移植后三个月内。术后前两周发生的肺炎无致命后果。移植后3至12周发生肺炎的患者白细胞减少症明显更严重(P小于0.05),且接受同种异体移植排斥治疗的情况比对照组更多(P小于0.01)。真菌性肺炎病例出现较晚,之前有排斥反应,预后较差。所有肺炎病例的死亡率为51.5%。早期诊断、及时给予特定抗菌药物以及立即停止免疫抑制治疗应能提高生存率。